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Introduction: Multipotent mesenchymal stromal cells (MSCs) have gained considerable interest because of their
potential use in the treatment of a variety of diseases and injuries. Although remarkable advancements have been
made in clinical studies, substantial concerns still regard the safety of MSCs. Some evidence suggests that MSCs can
spontaneously generate a population of cells with tumorigenic potential. Thus, studying the molecular mechanisms
that control the proliferation of MSCs may be a necessary step toward the development of strategies for safe
clinical practice. Ca2+ is a second messenger that mediates a wide range of cellular responses, including the
regulation of cell proliferation, but little is known about its function in MSCs. The aim of this study was to
investigate the effects of targeted Ca2+ buffering on MSCs proliferation in vitro.
Methods: Here, we used an adenoviral (Ad) vector encoding the Ca2+ chelator protein parvalbumin (PV) fused to a
nuclear exclusion signal (NES) and the Discosoma red fluorescent protein (DsRed) to investigate the function of
cytoplasmic Ca2+ signals on MSC proliferation. Confocal microscopy was used to demonstrate that PV-NES-DsRed was
expressed in the cytoplasm. Ca2+ signaling was monitored by using Fluo-4-AM. Fluorescence-activated cell sorting
(FACS) analysis of cells that were stained with propidium iodide was used as a quantitative measure of cell death. The
mitotic index was assessed by immunofluorescence, and the expression of cyclins was examined with Western blot.
Results: Our results show that the Ad-PV-NES-DsRed fusion protein decreased serum-induced Ca2+ signaling and blocked
the proliferation of rat adipose-derived MSCs (AT-MSCs) in prophase. FACS analysis revealed that Ad-PV-NES-DsRed did
not induce cell death in AT-MSCs. Furthermore, Western blot analysis demonstrated that Ad-PV-NES-DsRed reduced
extracellular signal-regulated kinase (Erk1/2) phosphorylation and cyclin B1 expression. Buffering cytosolic Ca2+ did not
alter the expression of cyclins A/D1/D2/D3/E and E2.
Conclusions: Our results show that cytoplasmic Ca2+ signals are important for AT-MSCs progression beyond prophase
because of their effects on Erk phosphorylation and cyclin B1 expression.
Keywords: Mesenchymal stem cells, Targeted parvalbumin, Calcium signaling, Proliferation, CyclinsIntroduction
Multipotent mesenchymal stromal cells (MSCs) are
nonhematopoietic stromal cells that have generated a
great amount of interest in the field of regenerative
medicine because of their unique biological properties.
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reproduction in any medium, provided the orcartilage, tendon, muscle, and adipose tissue [1], and they
have been isolated from different sources, such as bone
marrow, adipose tissue, peripheral blood, muscle, umbilical
blood, placenta, and other sites [2,3]. These cells are
relatively easy to obtain and have a remarkable capacity
for extensive in vitro expansion, which allows them rapidly
to reach the cell number required for in vivo therapy. In
addition to their secretion of multiple bioactive moleculesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Melo et al. Stem Cell Research & Therapy 2013, 4:92 Page 2 of 8
http://stemcellres.com/content/4/4/92with trophic effects, MCSs are able to migrate and to exert
immunomodulatory activities [4].
Over the past decade, many publications on MSCs
reported experimental and clinical applications for these
cells and demonstrated encouraging results. Although
tremendous advancements have been made in clinical
studies, substantial challenges remain and must be over-
come before MSCs therapy can fulfill its promise in wider
clinical practice [5].
The first major obstacle is definitively to determine the
safety of MSCs. A few studies support the idea that MSCs
suppress tumor growth, whereas others state that MSCs
may contribute indirectly to cancer by antiapoptotic effects
that protect tumors and by the promotion of tumor
progression, metastasis, and drug resistance. Alternatively,
MSCs may be directly involved in cancer development
through malignant transformation [6].
Some evidence suggests that these cells can spontan-
eously transform to generate a population of cells with
tumorigenic potential through the acquisition of point
mutations [7]. Some of these mutations are involved in
the expression of molecules that regulate the cell cycle
and cell proliferation [8]. Thus, studying the molecular
mechanisms involved in the cell cycle and proliferation
of MSCs may be the first step toward the development of
control strategies that prevent the proliferation of MSCs
that have undergone tumorigenic transformation after
transplantation for safe clinical practice.
Ca2+ is a second messenger that contributes to the
cell cycle and cell proliferation. In mammalian somatic
cells, the importance of intracellular Ca2+ signaling
during cell-cycle progression is well established [9], but
little is known about the effects of Ca2+ signals in the cell
cycle and proliferation of MSCs. The first studies in this
area used the microinjection of dextran-linked Ca2+ buffers,
but a more-efficient approach was subsequently developed
that used the targeted expression of Ca2+-buffering
proteins, such as parvalbumin (PV) or calretinin [10,11].
Here, we used a construct encoding PV that was targeted
to the cytoplasm by a nuclear export signal (PV-NES),
and we delivered these constructs to MSCs by using an
adenovirus (Ad) expression system to achieve high-efficiency
gene delivery. We used this strategy to examine the effects
of targeted Ca2+ buffering on cell populations. The PV
protein was fused to the Discosoma red fluorescent pro-
tein (DsRed) to monitor its expression and subcellular
localization. The aim of this study was to investigate the
effects of Ad-PV-NES-DsRed on MSCs proliferation
in vitro.
We found that Ad-PV-NES-DsRed could block MSC
proliferation during prophase because of its effects on
Erk phosphorylation and cyclin B1 expression. Thus, this
tool might provide a new perspective for understanding
and controlling MSC proliferation.Methods
Cell isolation and culture
Male Wistar rats (6 to 8 weeks old), which were obtained
from the Centro de Bioterismo da Universidade Federal
de Minas Gerais (CEBIO), were used for all of the studies.
Rat inguinal adipose tissue was dissected into small pieces,
digested with 0.15% collagenase B (Roche Applied Science,
Indianapolis, IN, USA) in 0.1 M phosphate-buffered saline
(PBS) for 40 minutes at 37°C. Mature adipocytes and
connective tissues were separated from the cell pellet by
centrifugation at 274.4 g for 10 minutes at room tem-
perature. The cell pellet was resuspended in high-glucose
Dulbecco modified Eagle medium (DMEM) (Sigma-Aldrich,
St. Louis, MO, USA) with 10% fetal bovine serum (FBS)
and 100 U/ml penicillin/streptomycin (Life Technologies,
Carlsbad, CA, USA). The current protocol was adapted
from a previously described protocol [12].
The initial passage of the primary cell culture was
referred to as passage 0. We used cells in passage 3
only, except in the indicated experiments. The cells were
maintained in complete media (DMEM + 10% FBS +
penicillin/streptomycin) until they achieved 75% to 90%
confluence. The cells were then replated in T75 tissue-
culture flasks. The identity of the MSCs was defined by
the criteria proposed by the International Society for
Cellular Therapy [13]. The experiments were approved by
the local ethical committee on animal experimentation
(CETEA/UFMG; protocol number 239/10).
Phenotypic analysis with flow cytometry
MSCs were recognized by using specific antibodies against
CD54, CD73, and CD90. In addition, we assessed the lack
of expression of the CD45 hematopoietic marker. All
antibodies were purchased from Becton Dickinson
(BD) Biosciences (San Jose, CA, USA). The secondary
antibodies used were conjugated to Alexa Fluor 488
(Life Technologies).
For immunophenotypic analysis, the MSCs were
detached by incubation with 0.05% trypsin-EDTA (Life
Technologies) for 5 minutes, immediately resuspended in
DMEM plus 10% FBS, and plated in 96-well culture plates
at a density of 2 × 105 cells/well. Next, the cells were
washed with PBS, and the cell suspension (100 μl) was
incubated at 4°C for 30 minutes with the primary antibody
(1:50) or with an isotype antibody (1:50) as a negative
control. Then, the plate was centrifuged at 274.4 g for
10 minutes at 10°C. After two washes with PBS, the cell
suspension was incubated at 4°C for 30 minutes with
the secondary antibody (1:200). Subsequently, the cells
were washed with PBS and analyzed with FACScan flow
cytometry by using CELLQuest software (BD Biosciences).
All fluorescence-activated cell-sorting (FACS) data were
analyzed by using FlowJo software (Tree Star, San Carlos,
CA, USA).
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Adenoviral constructs encoding DsRed (Ad-DsRed) and
the PV-DsRed fusion protein that was targeted to the
cytosol (Ad-PV-NES-DsRed) were obtained as previously
described [10]. The adenoviruses were amplified in HEK-
293 cells, a cell line that constitutively expresses the E1
protein. Both viruses (Ad-DsRed and Ad-PV-NES-DsRed)
were generated by using standard procedures and stored
at −80°C in PBS plus 7% glycerol. Stocks of the adenoviral
particles were quantified as plaque-forming units (pfus) by
using plaque assays in HEK-293 cells. On day 1 of culture,
each adenovirus construct (at a multiplicity of infection
(MOI) of 100) was diluted in regular culture medium
(DMEM) containing 10% FBS. The experiments were
performed at 36 to 48 hours, when approximately 70% of
the cells were transduced.
Ca2+ measurements
MSCs were cultured in 96-well culture plates at a density
of 1 × 104 cells/well and then transduced with the adeno-
viral constructs. After 24 hours, the cells were synchronized
to G0 by serum starvation overnight. The next morning,
the cells were washed in PBS and resuspended in HEPES
buffer containing 3 μM Fluo-4-AM (Life Technologies)
for 30 minutes at 37°C. Next, the cells were washed,
resuspended in HEPES, and then stimulated with HEPES
containing 10% FBS. The resultant fluorescent signal was
monitored for the whole well over time by using a Synergy
2 multimode plate reader (BioTek, Winooski, VT, USA).
The wavelength for excitation was 485/20 nm; emission
was measured at 530/25 nm, and the dichroic that was
used was the top 50%. The experiments were performed
at 37°C. The mean peaks of the maximum and minimum
fluorescence were analyzed by using Excel and plotted by
using GraphPad software (La Jolla, CA, USA).
Analysis of cell viability
To assess the cell viability of the MSCs, we used the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay (Life Technologies), as previously described
[14]. In brief, the MSCs were plated in 24-well culture
plates at a density of 1 × 105 cells/cm2 per well. MTT
(5 mg/ml) was added to each well of the monolayer
cultures, and the cultures were incubated in a humidified
5% CO2 incubator at 37°C. Two hours later, the cell
morphologies and formazan salts were visualized by using
an inverted optical microscope. The formazan salts were
dissolved with 10% SDS-HCl overnight, and the optical
density was measured at 595 nm by using a microplate
reader (Elx800; BioTek). Staurosporine was used as a
positive control for cell death at a concentration of
100 nM in DMEM containing 10% FBS. The values from
the samples are expressed as percentages of the control.
All data were analyzed by using GraphPad software.Analysis of cell death by flow cytometry
A flow-cytometric DNA fragmentation assay was used
as a quantitative measure of cell death [15]. Forty-eight
hours after transducing the MSCs with the adenoviral
constructs, the cells were collected by centrifugation and
lysed with 300 μl of a hypotonic solution containing
0.1% sodium citrate, 0.1% Triton X-100, and 20 μg/ml
propidium iodide (PI; Life Technologies). Then the cells
were incubated at room temperature for 1 hour and
analyzed with a FACScan flow cytometer (BD Biosciences)
for shifts in PI fluorescence, which are indicative of nuclei
with hypodiploid DNA content. All data were analyzed by
using FlowJo software (Tree Star).
Mitotic index measurements by immunofluorescence
Confocal immunofluorescence was performed as previously
described [10,16]. In brief, the cells were labeled with
an anti-phospho-histone-3 monoclonal antibody (1:500;
Millipore, Billerica, MA, USA) and then incubated with an
Alexa Fluor 488-conjugated secondary antibody (1:1,000;
Life Technologies) and the Hoechst nuclear stain
(200 ng/ml; Life Technologies). Images were captured by
using a Zeiss LSM 510 confocal microscope with a
63×/1.4 NA objective lens. The samples were excited at
488 nm and observed at 505 to 550 nm to detect Alexa
Fluor 488, excited at 405 nm, and observed at 420 to
460 nm to detect Hoechst staining. Mitotic indexes
were scored for the cells in each phase of mitosis
according to the phospho-histone-3 distribution and
DNA condensation pattern [10].
Immunoblotting
Immunoblotting was performed by using standard methods
[10,16]. In brief, the cells, which were grown in T75 tissue-
culture flasks, were washed 3 times with PBS and lysed in
buffer containing 150 mM NaCl, 1 mM EDTA, 20 mM
Tris–HCl, 0.5% Nonidet P-40, and a protease-inhibitor
mixture (Sigma-Aldrich). The protein concentration was
determined spectrophotometrically by using the Bradford
method (Sigma-Aldrich), and 40 μg of protein was sepa-
rated by electrophoresis in a 4% to 15% polyacrylamide
gel and then transferred to a polyvinylidene difluoride
membrane (Millipore). The membrane was blocked with
5% skim milk in Tris-buffered saline (TBS) plus 0.5%
Tween 20 (TBST) for 60 minutes and then incubated with
primary antibodies against total Erk1/2 or phospho-Erk1/2
(1:1,000; Cell Signaling Technology, Beverly, MA, USA),
cyclins A, B1, D1, D2, D3, E, or E2 (1:500 to 1,000, Cell
Signaling Technology) or GAPDH (1:500; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The incubations with
the primary antibodies were carried out overnight. After
three 5-minute washes with TBST, the membranes were
incubated with the appropriate horseradish peroxidase-
conjugated secondary antibody (1:5,000) (Sigma-Aldrich)
Figure 1 Phenotypic analysis of rat MSCs. (A) FACS analysis of
CD45, CD54, CD73, and CD90 antigens in rat MSCs (gray bars). Solid
black bars refer to the negative controls (cells incubated with
isotype IgG control and secondary antibody). (B) Quantitative
analysis of the expression pattern of rat MSCs. The control group
comprised cells that were not incubated with the Alexa Fluor
488-conjugated secondary antibody. The secondary antibody
(sec. antibody) group comprised cells that were incubated with the
isotype IgG control and secondary antibody alone. *P < 0.001
compared with control; N = 3 (three experiments that were
conducted independently).
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5-minute washes with TBST, the membranes were devel-
oped by using enhanced chemiluminescence (ECL Plus;
GE Healthcare Life Sciences, Piscataway, NJ, USA). Subse-
quently, the films were scanned and analyzed by using
Image J software.
Statistical analysis
All of the data shown represent at least three independent
experiments and are expressed as the mean ± standard
error of the mean (SEM). The statistical analyses were
performed with GraphPad software. The experiments
with more than two data groups were compared by using
one-way ANOVA and the Bonferroni posttest. P values
of <0.05 were considered to be statistically significant.
Results
Characterization of rat MSCs
Rat MSCs were characterized according to the three
criteria proposed by the Mesenchymal and Tissue Stem
Cell Committee of the International Society for Cellular
Therapy [13]. First, the cell-surface antigen profile was
ascertained by staining the cells with rat-specific monoclonal
antibodies, followed by flow-cytometric analyses, as shown
in Figure 1. We investigated the expression of the cell
markers CD54 (99.1% ± 0.4%), CD73 (99.5% ± 0.2%),
CD90 (90.3% ± 0.6%), and CD45 (10.3% ± 0.3%). Second,
we demonstrated that the MSCs were plastic-adherent
when maintained in standard culture conditions, and
fibroblast-like, as they appeared polygon-like or spindle-like
with processes (data not shown). Third, we showed that
the MSCs were capable of differentiating into osteoblasts
and adipocytes (data not shown).
Cytoplasmic-targeted parvalbumin decreases
agonist-induced Ca2+ signals
The relative role of cytoplasmic Ca2+ signals in specific cell
functions can be determined by selectively attenuating
Ca2+ increases in the cytoplasm with Ad-PV-NES-DsRed,
as shown previously [10,17]. In this study, confocal micros-
copy demonstrated that PV-NES-DsRed was expressed in
the cytoplasm and that DsRed alone was expressed in both
the cytoplasm and nucleus (Figure 2A). We used 10%
serum stimulation to test the efficiency of Ad-PV-NES-
DsRed in attenuating agonist-induced Ca2+ signaling in
MSCs. The expression of Ad-PV-NES-DsRed was able to
attenuate locally 74% ± 2% of the cytoplasmic Ca2+ signals
(Figure 2B).
Cytosolic Ca2+ blocks MSC proliferation at prophase
To determine the involvement of cytoplasmic Ca2+ in MSC
proliferation, the effect of the expression of our Ca2+
chelator fusion protein, PV-NES-DsRed, in MSCs was
examined. First, the cells were synchronized to G0 byserum starvation and then transduced with the adenoviral
constructs. Next, the cells were stimulated with complete
medium to reenter the cell cycle. After 48 hours, the
metabolization of MTT was reduced in cells that were
transduced with Ad-PV-NES-DsRed compared with
cells grown without serum, whereas no reduction in
the metabolization of MTT was observed in cells that
expressed the adenoviral transduction control Ad-DsRed
compared with cells grown with serum (Figure 3A).
Furthermore, flow-cytometric analysis of cells stained
with propidium iodide showed that Ad-PV-NES had
no effect on cell death (Figure 3B). These results suggest
that the effects of Ad-PV-NES were specific to MSCs
proliferation.
Second, to investigate the effects of cytoplasmic Ca2+
on mitosis, the MSCs were labeled with the mitotic
marker phospho-histone-3. After 48 hours of adenoviral
Figure 3 Parvalbumin targeted to the cytoplasm specifically
inhibits MSC proliferation. (A) MTT assay of MSCs after 48 hours of
transduction with Ad-PV-NES-DsRed. The metabolization of MTT was
reduced in cells that were transduced with Ad-PV-NES-DsRed
compared with cells grown with serum (P < 0.01), whereas no
reduction in the metabolization of MTT was observed in cells that
expressed the adenoviral transduction control Ad-DsRed compared
with cells grown with serum (P > 0.05) (n = 3). (B) Flow-cytometric
assays were used to measure cell death quantitatively after cells
were stained with PI. The cells were examined 48 hours after
transduction. The results are expressed as the percentage of events
from a total of 20,000 events (n = 3). *P < 0.01 compared with cells
grown in 10% serum. **P < 0.05 cells grown without serum
compared with cells treated with 200 nM staurosporine.
Figure 2 Parvalbumin attenuates serum-induced Ca2+ signaling
in MSCs. (A) Analysis of parvalbumin protein localization by
confocal microscopy. Ad-PV-NES-DsRed was expressed in the
cytoplasm, and ad-DsRed alone, which served as a control, was
expressed in both compartments. In each image, red indicates
DsRed, blue indicates Hoechst nuclear staining, and purple
represents the colocalization of the two signals. (B) Effect of
parvalbumin on Ca2+ signaling. The cells were examined 48 hours
after being transduced with the indicated adenoviral constructs and
were synchronized to G0 by serum starvation overnight. Ca
2+ was
monitored with Fluo-4-AM by using a fluorescence microplate
reader in cells that were stimulated with 10% serum. Ad-PV-NES-
DsRed (Ad-PV-NES) attenuated the serum-induced increase in Ca2+
(P < 0.05). Ca2+ signals were not attenuated in cells that expressed
ad-DsRed alone (P > 0.05). The results are representative of three
independent experiments. Scale bar, 20 μm.
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croscopy to determine the fraction of cells in mitosis
(Figure 4B). The mitotic index was increased to 61% ± 2%
in cells with buffered cytoplasmic Ca2+ (P < 0.001). In
addition, 49.9% of the cells in mitosis were in prophase
(Figure 5B). No significant effect was observed upon com-
parison of uninfected cells with Ad-DsRed-transduced
cells (Figure 4B). These results demonstrate that cyto-
plasmic Ca2+ is important for the cell-cycle transition of
MSCs beyond prophase.
To determine whether the expression of Ad-PV-NES-
DsRed specifically affected the G2/M transition, we ex-
amined the expression of cyclin B1, a G2/M-checkpoint
protein. The expression of total cyclin B1 was decreased
in cells expressing Ad-PV-NES-DsRed (Figure 5A and B).
To confirm that Ad-PV-NES-DsRed expression does notinhibit progression through the earlier phases of the cell
cycle, we investigated the expression of G1/S and S/G2
checkpoint proteins, cyclins A/D1/D2/D3, and cyclins
E/E2, respectively. Buffering cytosolic Ca2+ did not alter
the expression of any of these checkpoint proteins
(Figure 6A and B). To examine further the effects of
cytosolic Ca2+ on cell proliferation, the effect of PV-NES
on the expression level of the growth-related kinase Erk1/2
was examined, and buffering cytoplasmic Ca2+ was found
to decrease the level of phospho-Erk1/2 (Figure 6A and B).
Together, these observations suggest that Ad-PV-NES-
DsRed acts during, but not before, mitosis to regulate
MSCs proliferation.Discussion
Recent clinical trials that tested MSCs for the treatment
of debilitating disorders, such as osteogenesis imperfecta
Figure 4 Cytosolic Ca2+ regulates the progression of MSCs
through prophase. (A) Representative images of MSCs in prophase,
metaphase, anaphase, and telophase. The confocal immunofluorescent
images were obtained after staining with anti-phospho-histone-3
(green) and Hoechst dye (blue) to label the nucleus. Scale bar = 20
μm. (B) Mitotic MSCs were identified by phospho-histone-3 labeling
and measured 48 hours after transduction with the indicated
adenoviral constructs. Approximately 10 random fields were
analyzed by using an Olympus IX70 inverted epi-fluorescent
microscope to determine the average number of cells in the
samples (61 to 70 cells were analyzed in each experimental group).
The mitotic index increased to 61% ± 2% in cells in which cytosolic
Ca2+ was buffered (*P < 0.001). In addition, 49.9% of the mitotic
cells were in prophase.
Figure 5 Cytosolic Ca2+ regulates expression of cyclin B1. (A)
Immunoblot analysis of cells that were transduced with the Ad-
PV-NES-DsRed construct. The expression of cyclin B1 was decreased
in the presence of the PV-NES-DsRed protein, but no changes were
observed in the expression of the cell-cycle checkpoint proteins
cyclins A, D1, D2, D3, E, or E2. GAPDH was used as a loading
control. (B) Bar-graph summary showing that Ad-PV-NES-DsRed
decreased the expression of cyclin B1 by 86% ± 7% (n = 3).
*P < 0.05.
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[18]. Numerous preclinical studies have established the
therapeutic potential of MSCs in tissue engineering and as
cellular protein factories for the delivery of cytokines and
anticancer agents [19]. However, although MSC therapy
has gained popularity among practitioners and researchers,
reports indicated the adverse effects of MSCs, especially
in the context of tumor modulation and malignant trans-
formation [6]. Here, we demonstrated that parvalbumin
that was targeted to the cytoplasm induced cell-cyclearrest at prophase in rat MSCs. Genetically modified
MSCs have been successfully evaluated in animal models
for diabetes, skeletal defects, and myocardial infarction
[20]. We speculate that genetically modified MSCs, such
as the MSCs expressing Ad-PV-NES-DsRed in our study,
could be a valuable tool for understanding and controlling
MSC proliferation.
The concept that Ca2+ signals regulate rat MSC prolifera-
tion at the level of the prophase-to-metaphase transition is
interesting and novel. We used a cytoplasmic parvalbumin
fusion protein as an alternative for intracellular Ca2+ che-
lators, such as BAPTA-AM. PV constructs have the ability
to attenuate Ca2+ signals specifically to avoid cell death,
which is normally observed after long periods of treatment
with BAPTA-AM [21]. Increases in the free Ca2+ concen-
tration in the cytosol are associated with progression
through the cell cycle [22-24]. Increasing evidence suggests
that the spatial and temporal patterns of Ca2+ signals may
determine their specificity for the transitions between each
phase of the cell cycle. The cell-cycle arrest observed at
prophase in cells expressing Ad-PV-NES-DsRed could be
attributed to the ability of this protein to attenuate Ca2+
signals specifically.
Figure 6 Cytosolic Ca2+ regulates Erk1/2 phosphorylation. (A)
Immunoblot analysis of cells that were transduced with the Ad-
PV-NES-DsRed construct. Erk1/2 phosphorylation was decreased in
the presence of the PV-NES-DsRed protein. Total Erk1/2 was used as
a loading control. (B) Bar-graph summary showing that Ad-PV-NES-
DsRed decreased Erk1/2 phosphorylation by 69% ± 5% (n = 3).
*P < 0.05.
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that targeted PV constructs can efficiently alter Ca2+
signal profiles and arrest cell-cycle progression at mi-
tosis, but the effects that we observed in the expression
of cyclin B1 were not observed in MSCs or other cell
models to date [10,17,25]. The cyclin B1/Cdk1 complex
regulates many of the dramatic cellular rearrangements
observed during mitosis [26]. Cdk1 activation is a multi-
step process that begins when it binds to its regulatory
subunit cyclin B, which increases in expression during G2
and peaks in mitosis [27]. Before mitosis, cyclin B/Cdk1
complexes are held in an inactive state by Cdk1 phosphor-
ylation, which is catalyzed by the protein kinases Wee1
and Myt1. Dephosphorylation of Cdk1 is carried out by
the protein phosphatase cell-division cycle 25 homolog C
(Cdc25C).
Activation of Cdc25C requires the phosphorylation of
several sites in the Cdc25C amino-terminal domain [27].
Although the phosphorylation of cyclin B does not
appear to regulate the enzymatic activity of the com-
plex, the subcellular localization of the cyclin B1/Cdk1
complex is controlled through the phosphorylation of
four serines (Ser 94, 96, 101, and 113 in Xenopus) within
a region of cyclin B1 that is known as the cytoplasmic
retention sequence (CRS) [26]. The phosphorylation of
the first two CRS serines (Ser 94 and 96) is catalyzed byErk in the Xenopus system [26]. During mitosis, these
cyclin B1 phosphorylations trigger a decrease in export
and an increase in import, resulting in nuclear trans-
location. In late prophase, most cyclin B1/Cdk1 com-
plexes are rapidly translocated from the cytoplasm to
the nucleus, after which the nuclear envelope breaks
down [27].
In this study, we demonstrated that the attenuation of
Ca2+ signals by Ad-PV-NES-DsRed decreased cyclin B1
expression and Erk phosphorylation, and we hypothesize
that these effects caused cell-cycle arrest at prophase.
The immediate-early gene transcription and early phos-
phorylation of Erk and cAMP response element-binding
(CREB) have been reported as crucial events for cell-cycle
progression and are dependent on cytosolic Ca2+ signaling
[10,17,28].
Therefore, this tool may represent a new method to
control MSC proliferation in vitro. Further research is
required to identify the targets of cytosolic Ca2+ signals
for MSC proliferation.Conclusions
Cytoplasmic Ca2+ signals are important for the cell-cycle
progression of MSCs beyond prophase because of their
effects on Erk phosphorylation and cyclin B1 expression.
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